Northland Securities Forecasts Ambarella Q3 Earnings
Northland Securities has revised its Q3 2027 EPS forecast for Ambarella to a loss of $0.15 per share, an improvement from its previous projection of a $0.20 loss. The firm also provided updated earnings estimates for FY2027 and FY2028. This adjustment follows Ambarella's recent outperformance in quarterly earnings, though analyst sentiment on the stock remains mixed with a consensus "Hold" rating.
ATIF Holdings Limited Completes Acquisition of GoldCoin Labs, Expanding into Gold-Backed Digital Asset Sector
ATIF Holdings Limited (Nasdaq: AUC) has completed its acquisition of GoldCoin Labs Limited, a British Virgin Islands company specializing in gold-backed digital asset infrastructure. The acquisition, valued at approximately $20 million, involves GoldCoin's development of Metra Gold (GOLDM), a tokenized digital representation of physical gold, which will be 1:1 backed by physical gold meeting LBMA standards. This strategic move expands ATIF Holdings' presence in the tokenized real-world asset sector and diversifies its business by adding gold-tokenization to its existing digital asset strategy.
Targa Resources (NYSE:TRGP) Receives Buy Rating from Stifel Nicolaus
Stifel Nicolaus reaffirmed its "buy" rating for Targa Resources (NYSE:TRGP), setting a price target of $340, which suggests a 16.66% upside. Despite beating EPS estimates, the company's revenue for the quarter fell short of forecasts. Institutional investors hold a significant portion of the company's stock, while insiders have recently sold shares.
ATIF Holdings completes acquisition of GoldCoin Labs By Investing.com
ATIF Holdings Limited has completed its acquisition of GoldCoin Labs Limited, a British Virgin Islands company focused on developing gold-backed digital asset issuance infrastructure. The transaction involved ATIF issuing over 2.8 million ordinary shares, valued at approximately $20 million, to GoldCoin's sole shareholder. This acquisition expands ATIF's focus into digital assets, including gold-backed tokens intended to represent physical gold.
Devon Energy (NYSE:DVN) Given Buy Rating at Stifel Nicolaus
Stifel Nicolaus reiterated a "buy" rating for Devon Energy (NYSE:DVN) with a $61.00 price target, suggesting a 24.45% upside. This aligns with a consensus "Moderate Buy" rating from analysts, with an average target of $59.30. Devon Energy recently exceeded quarterly earnings estimates, reporting $1.57 EPS on $7.42 billion in revenue.
BTIG Research Boosts Equinix (NASDAQ:EQIX) Price Target to $1,240.00
BTIG Research has increased its price target for Equinix (NASDAQ:EQIX) to $1,240.00 from $1,210.00, maintaining a "buy" rating. This new target suggests an 18.88% upside from the previous closing price. Equinix recently reported strong quarterly earnings of $11.78 per share, significantly surpassing the consensus estimate of $4.73, with revenue growing 16.4% year-over-year to $2.62 billion.
Huntington Bancshares names Brantley J. Standridge as president By Investing.com
Huntington Bancshares Incorporated has appointed Brantley J. Standridge as president of the company and its subsidiary, The Huntington National Bank, effective Monday. Standridge, 50, previously served in various senior leadership roles at Huntington and Truist Financial Corporation. His new role comes with an increased base salary and higher annual and long-term incentive plan targets.
Solitario Resources CEO to Present at HC Wainwright 28th Annual Global Investment Conference
Solitario Resources Corp. (NYSE American: XPL, TSX: SLR) announced that CEO Chris Herald will present at the 28th Annual Global Investment Conference hosted by H.C. Wainwright & Co. The presentation is scheduled for September 15, 2026, at 2:30 pm ET, with one-on-one investor meetings also scheduled on September 14 and 15. The company will provide updates on its five resource and exploration projects, including Golden Crest, Cat Creek, Bright Angel, Lik zinc deposit, and Florida Canyon zinc project.
Adagene, Third Arc Bio expand partnership with first lead selection By Investing.com
Adagene Inc. announced that Third Arc Bio has selected the first lead candidate under their expanded strategic licensing agreement, which was originally established in November 2025. This expansion increases potential payments to Adagene, including development and commercial milestones, while Adagene retains commercialization rights in Greater China, Singapore, and South Korea. The collaboration leverages Adagene's NEObody and SAFEbody technology platforms for masked CD3 T cell engagers against tumor-associated antigens.
Why Is T-Mobile (NASDAQ:TMUS) Worried About Starlink Rivalry?
T-Mobile (NASDAQ:TMUS) shares traded lower following new comments about Starlink's customer acquisition, sparking renewed debate over satellite competition. While a separate review highlighted T-Mobile's wireless operating gains, the market is scrutinizing how subscriber trends and network economics will be impacted. The article emphasizes that investors are focused on how T-Mobile will address competitive pressures and manage its operating trajectory amidst this evolving landscape.
